This medical records analysis from a single institution in Japan assesses anti–PD-1 treatment in patients with subclinical advanced non–small cell lung cancer and with or without preexisting autoimmune markers and evaluates potential clinical biomarkers that may be associated with clinical benefit or with immune-related adverse events.
http://bit.ly/2QSMu4I
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Abstract The changes of dissolved organic matter (DOM) components during stabilization process play significant effects on its redox prope...
-
Publication date: September 2017 Source: European Journal of Surgical Oncology (EJSO), Volume 43, Issue 9 http://ift.tt/2gezJ2D
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου